Private MarketsSmartkarma Newswire

Top 10 Highlights from the APAC PE, VC and Startup Ecosystem this Week – 24 Dec 2023

By December 24, 2023 No Comments

Top ten highlights from the APAC PE, VC, and startup ecosystem this week:

  1. General Atlantic is reportedly in talks to acquire Actis, an infrastructure investor.
  2. Capsquare Asia Partners, a PE firm based in Indonesia, is looking to raise $250 million for its third growth fund.
  3. Manulife Investment Management sees India and Japan as standout markets, presenting investment opportunities.
  4. Tikehau Capital and Nikko Asset Management are in discussions for an alliance and potential joint venture in Asian private markets.
  5. Novo Tellus, a Singapore-based PE firm, has closed its third fund at $510 million, exceeding its target.
  6. International Finance Corporation (IFC) is investing $50 million in A.P. Moller Capital’s latest infrastructure fund.
  7. Amicus Capital, an Indian PE firm, receives $40 million from the European Investment Bank for investments in small and medium enterprises.
  8. Healthcare investment firm Vivo Capital has closed an RMB-denominated fund at almost 10 billion yuan.
  9. GL Capital Group, led by former Novartis China head Jeffrey Li, has raised $162.5 million for its fourth USD-denominated PE fund.
  10. OCBC, a Singaporean lender, plans to create a $500 million fund to finance decarbonization-related businesses in Southeast Asia.

APAC Private Markets Research

Explore latest Insights on APAC Private Markets on Smartkarma


Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars

Also, check out the latest in ECM Research on Smartkarma